Chronic kidney disease (CKD) progression involves morphological changes in the kidney, such as decreased length and thickness, with associated histopathological alterations. However, the relationship between morphological changes in the kidneys and glomerular filtration rate (GFR) has not been quantitatively and comprehensively evaluated. We evaluated the three-dimensional size and shape of the kidney using computed tomography (CT)-derived features in relation to kidney function. We included 257 patients aged ≥18 years who underwent non-contrast abdominal CT at the Inha University Hospital. The features were quantified using predefined algorithms in the pyRadiomics package after kidney segmentation. All features, except for flatness, significantly correlated with estimated GFR (eGFR). The surface-area-to-volume ratio (SVR) showed the strongest negative correlation (r = −0.75, p < 0.0001). Kidney size features, such as volume and diameter, showed moderate to high positive correlations; other morphological features showed low to moderate correlations. The calculated area under the receiver operating characteristic (ROC) curve (AUC) for different features ranged from 0.51 (for elongation) to 0.86 (for SVR) for different eGFR thresholds. Diabetes patients had weaker correlations between the studied features and eGFR and showed less bumpy surfaces in three-dimensional visualization. We identified alterations in the CKD kidney based on various three-dimensional shape and size features, with their potential diagnostic value.
Endometrial cancer (EC) is one of the most pervasive malignancies in females worldwide. HOXA5 is a member of the homeobox (HOX) family and encodes the HOXA5 protein. HOXA5 is associated with various cancers; however, its association with EC remains unclear. This study aimed to determine the association between HOXA5 gene expression and the prognosis of endometrioid adenocarcinoma, a subtype of EC (EAEC). Microarray data of HOXA5 were collected from the Gene Expression Omnibus datasets, consisting of 79 samples from GSE17025 and 20 samples from GSE29981. RNA-sequencing, clinical, and survival data on EC were obtained from The Cancer Genome Atlas cohort. Survival analysis revealed that HOXA5 overexpression was associated with poor overall survival in patients with EAEC (p = 0.044, HR = 1.832, 95% CI = 1.006–3.334). Cox regression analysis revealed that HOXA5 was an independent risk factor for poor prognosis in EAEC. The overexpression of HOXA5 was associated with a higher histological grade of EAEC, and it was also associated with TP53 mutation or the high copy number of EC. Our findings suggest the potential of HOXA5 as a novel biomarker for predicting poor survival outcomes in patients with EAEC.
Purpose: This study aimed to evaluate the diagnostic accuracy of 18F-Florastamin prostate-specific membrane antigen (PSMA) positron emission tomography-computed tomography (PET/CT) in detecting intermediate-risk prostate cancer and compare its performance with multiparametric magnetic resonance imaging (mpMRI). Patients and Methods: Fifty-nine patients with suspected intermediate-risk prostate cancer (prostate-specific antigen: 3–20 ng/mL) were prospectively enrolled. All participants underwent examination with 18F-Florastamin PET/CT and mpMRI, with imaging results assessed using the PSMA-Reporting and Data System and Prostate Imaging-Reporting and Data System Version 2.1 scoring systems, respectively. Prostate biopsy served as the reference standard. Diagnostic metrics, including sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), accuracy, and area under the receiver operating characteristic curve (AUC), were calculated to compare the 2 modalities. Results: PSMA PET/CT demonstrated a sensitivity of 72.4%, specificity of 83.3%, and overall accuracy of 78%, with an AUC of 0.78 (95% CI: 0.67–0.89). Contrastingly, mpMRI showed a higher sensitivity (89.7%) but lower specificity (66.7%), achieving the same overall accuracy of 78% and an AUC of 0.78 (95% CI: 0.68–0.88). No statistically significant difference in AUC was observed between the 2 modalities (P=0.967). While PSMA PET/CT offered higher specificity and PPV, reducing false-positive results, mpMRI excelled in sensitivity and NPV, minimizing false negatives. Conclusions: 18F-Florastamin PSMA PET/CT demonstrated comparable diagnostic accuracy to mpMRI, with the added benefit of higher specificity. These findings suggest that PSMA PET/CT could complement mpMRI in the diagnostic evaluation of intermediate-risk prostate cancer, enhancing patient stratification and aiding clinical decision-making.
1 January 2025 in Journal of the Korean Society of Radiology
Background/Objectives: Skeletal muscle depletion is an important extrapulmonary manifestation of chronic obstructive pulmonary disease (COPD) and is associated with adverse clinical outcomes. Chest computed tomography (CT), which is frequently performed in patients with COPD, provides an opportunity for opportunistic assessment of thoracic muscle mass. However, the prognostic relevance of CT-derived pectoralis muscle measurements for long-term survival in COPD remains incompletely defined. This study aimed to evaluate the association between CT-derived pectoralis muscle measurements and all-cause mortality in patients with COPD and to compare the prognostic relevance of absolute muscle area and a height-adjusted index. Methods: In this retrospective cohort study, 245 patients with COPD who underwent chest CT were included. Pectoralis muscle area (PMA) was measured on a single axial image at the level of the fourth thoracic vertebra using a semi-automated segmentation method, and the pectoralis muscle index (PMI) was calculated by normalizing PMA to height squared. The primary endpoint was all-cause mortality. Multivariable Cox proportional hazards regression analyses were performed to assess the associations between muscle measurements and mortality, adjusting for age, sex, and selected clinical covariates. Hazard ratios (HRs) were expressed per 100-unit increase in PMA (mm2) and PMI. Results: During a mean follow-up of 5.31 ± 3.93 years, 178 deaths (72.7%) occurred. In multivariable analyses, higher PMA was significantly associated with a lower risk of all-cause mortality (HR per 100 mm2 increase, 0.951; 95% confidence interval [CI], 0.933–0.969; p < 0.001). Similarly, higher PMI was significantly associated with lower mortality (HR per 100-unit increase in PMI, 0.879; 95% CI, 0.834–0.925; p < 0.001). In sex-stratified analyses, these associations remained significant in men but not in women. Conclusions: CT-derived pectoralis muscle measurements were significantly associated with all-cause mortality in patients with COPD. Both absolute muscle area and height-adjusted indices demonstrated consistent prognostic value. Opportunistic assessment of thoracic muscle on routine chest CT may provide a useful imaging biomarker for risk stratification in COPD.
1 January 2024 in Journal of the Korean Society of Radiology